| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GDP binding | 2.98e-14 | 103 | 46 | 10 | GO:0019003 | |
| GeneOntologyMolecularFunction | G protein activity | 8.48e-13 | 59 | 46 | 8 | GO:0003925 | |
| GeneOntologyMolecularFunction | GTPase activity | 2.40e-10 | 341 | 46 | 11 | GO:0003924 | |
| GeneOntologyMolecularFunction | GTP binding | 1.19e-09 | 397 | 46 | 11 | GO:0005525 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 3.42e-09 | 439 | 46 | 11 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 3.42e-09 | 439 | 46 | 11 | GO:0019001 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RIT1 HRAS KRAS KIF28P RAB28 RAP2A RAP2B NRAS RAB14 RAP2C LSG1 RIT2 | 1.24e-07 | 775 | 46 | 12 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RIT1 HRAS KRAS KIF28P RAB28 RAP2A RAP2B NRAS RAB14 RAP2C LSG1 RIT2 | 2.91e-07 | 839 | 46 | 12 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RIT1 HRAS KRAS KIF28P RAB28 RAP2A RAP2B NRAS RAB14 RAP2C LSG1 RIT2 | 2.95e-07 | 840 | 46 | 12 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RIT1 HRAS KRAS KIF28P RAB28 RAP2A RAP2B NRAS RAB14 RAP2C LSG1 RIT2 | 2.95e-07 | 840 | 46 | 12 | GO:0016818 |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 6.91e-04 | 17 | 46 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.76e-03 | 27 | 46 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 3.01e-03 | 627 | 46 | 6 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 3.99e-03 | 664 | 46 | 6 | GO:0008324 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 4.19e-03 | 465 | 46 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | frizzled binding | 4.22e-03 | 42 | 46 | 2 | GO:0005109 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 4.83e-03 | 45 | 46 | 2 | GO:0043495 | |
| GeneOntologyBiologicalProcess | Rap protein signal transduction | 3.71e-06 | 14 | 46 | 3 | GO:0032486 | |
| GeneOntologyBiologicalProcess | Ras protein signal transduction | 9.51e-06 | 128 | 46 | 5 | GO:0007265 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | 2.22e-05 | 538 | 46 | 8 | GO:0007264 | |
| GeneOntologyBiologicalProcess | neural plate elongation | 2.91e-05 | 4 | 46 | 2 | GO:0014022 | |
| GeneOntologyBiologicalProcess | convergent extension involved in neural plate elongation | 2.91e-05 | 4 | 46 | 2 | GO:0022007 | |
| GeneOntologyBiologicalProcess | microvillus assembly | 3.27e-05 | 28 | 46 | 3 | GO:0030033 | |
| GeneOntologyBiologicalProcess | positive regulation of protein autophosphorylation | 3.64e-05 | 29 | 46 | 3 | GO:0031954 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | DVL2 HRAS KRAS PTPN13 RAP2A RAP2B NRAS RAP2C ENO1 ALK RIT2 DVL1 | 4.72e-05 | 1421 | 46 | 12 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | DVL2 HRAS KRAS PTPN13 RAP2A RAP2B NRAS RAP2C ENO1 ALK RIT2 DVL1 | 4.78e-05 | 1423 | 46 | 12 | GO:0051174 |
| GeneOntologyBiologicalProcess | localization within membrane | 5.65e-05 | 798 | 46 | 9 | GO:0051668 | |
| GeneOntologyBiologicalProcess | microvillus organization | 5.92e-05 | 34 | 46 | 3 | GO:0032528 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | 6.07e-05 | 1226 | 46 | 11 | GO:0042325 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to synapse | 8.29e-05 | 38 | 46 | 3 | GO:1902473 | |
| GeneOntologyBiologicalProcess | acetyl-CoA metabolic process | 8.97e-05 | 39 | 46 | 3 | GO:0006084 | |
| GeneOntologyBiologicalProcess | convergent extension involved in organogenesis | 1.01e-04 | 7 | 46 | 2 | GO:0060029 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | 1.03e-04 | 863 | 46 | 9 | GO:0031344 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 1.03e-04 | 494 | 46 | 7 | GO:0031346 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | 1.18e-04 | 879 | 46 | 9 | GO:0045937 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | 1.18e-04 | 879 | 46 | 9 | GO:0010562 | |
| GeneOntologyBiologicalProcess | protein localization to synapse | 1.25e-04 | 115 | 46 | 4 | GO:0035418 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection arborization | 1.35e-04 | 8 | 46 | 2 | GO:0150012 | |
| GeneOntologyBiologicalProcess | regulation of protein autophosphorylation | 1.47e-04 | 46 | 46 | 3 | GO:0031952 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 1.50e-04 | 228 | 46 | 5 | GO:0046777 | |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | 1.60e-04 | 1133 | 46 | 10 | GO:0001932 | |
| GeneOntologyBiologicalProcess | neural plate morphogenesis | 1.73e-04 | 9 | 46 | 2 | GO:0001839 | |
| GeneOntologyBiologicalProcess | convergent extension involved in gastrulation | 2.64e-04 | 11 | 46 | 2 | GO:0060027 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | 2.94e-04 | 780 | 46 | 8 | GO:0042327 | |
| GeneOntologyBiologicalProcess | insulin processing | 3.17e-04 | 12 | 46 | 2 | GO:0030070 | |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 3.29e-04 | 148 | 46 | 4 | GO:1902414 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 3.83e-04 | 612 | 46 | 7 | GO:0010975 | |
| GeneOntologyBiologicalProcess | neural plate development | 4.35e-04 | 14 | 46 | 2 | GO:0001840 | |
| GeneOntologyBiologicalProcess | neuron projection development | 4.41e-04 | 1285 | 46 | 10 | GO:0031175 | |
| GeneOntologyBiologicalProcess | regulation of protein tyrosine kinase activity | 4.91e-04 | 69 | 46 | 3 | GO:0061097 | |
| GeneOntologyBiologicalProcess | regulation of establishment of planar polarity involved in neural tube closure | 5.02e-04 | 15 | 46 | 2 | GO:0090178 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection arborization | 5.02e-04 | 15 | 46 | 2 | GO:0150011 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | 5.06e-04 | 846 | 46 | 8 | GO:0120035 | |
| GeneOntologyBiologicalProcess | establishment of planar polarity involved in neural tube closure | 5.72e-04 | 16 | 46 | 2 | GO:0090177 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin E stimulus | 5.72e-04 | 16 | 46 | 2 | GO:0071380 | |
| GeneOntologyBiologicalProcess | morphogenesis of a polarized epithelium | 5.79e-04 | 73 | 46 | 3 | GO:0001738 | |
| GeneOntologyBiologicalProcess | establishment of endothelial intestinal barrier | 6.48e-04 | 17 | 46 | 2 | GO:0090557 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic membrane | 6.77e-04 | 77 | 46 | 3 | GO:1903539 | |
| GeneOntologyBiologicalProcess | establishment of planar polarity of embryonic epithelium | 7.28e-04 | 18 | 46 | 2 | GO:0042249 | |
| GeneOntologyBiologicalProcess | protein localization to postsynapse | 7.56e-04 | 80 | 46 | 3 | GO:0062237 | |
| GeneOntologyBiologicalProcess | regulation of establishment of planar polarity | 8.12e-04 | 19 | 46 | 2 | GO:0090175 | |
| GeneOntologyBiologicalProcess | convergent extension | 8.12e-04 | 19 | 46 | 2 | GO:0060026 | |
| GeneOntologyBiologicalProcess | regulation of neuronal synaptic plasticity | 8.42e-04 | 83 | 46 | 3 | GO:0048168 | |
| GeneOntologyBiologicalProcess | dendrite development | 8.71e-04 | 335 | 46 | 5 | GO:0016358 | |
| GeneOntologyBiologicalProcess | protein localization to membrane | 8.87e-04 | 705 | 46 | 7 | GO:0072657 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | 9.16e-04 | 512 | 46 | 6 | GO:0009150 | |
| GeneOntologyBiologicalProcess | JNK cascade | 9.81e-04 | 198 | 46 | 4 | GO:0007254 | |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | 1.04e-03 | 724 | 46 | 7 | GO:0001934 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | 1.13e-03 | 533 | 46 | 6 | GO:0009259 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 1.19e-03 | 23 | 46 | 2 | GO:0071379 | |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | 1.21e-03 | 540 | 46 | 6 | GO:0019693 | |
| GeneOntologyBiologicalProcess | neuron development | 1.21e-03 | 1463 | 46 | 10 | GO:0048666 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | 1.37e-03 | 1488 | 46 | 10 | GO:0031399 | |
| GeneOntologyBiologicalProcess | glycolytic process through glucose-6-phosphate | 1.41e-03 | 25 | 46 | 2 | GO:0061620 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane | 1.41e-03 | 25 | 46 | 2 | GO:0098696 | |
| GeneOntologyBiologicalProcess | response to prostaglandin E | 1.53e-03 | 26 | 46 | 2 | GO:0034695 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 1.65e-03 | 27 | 46 | 2 | GO:0035235 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide biosynthetic process | 1.76e-03 | 232 | 46 | 4 | GO:0009152 | |
| GeneOntologyBiologicalProcess | thioester metabolic process | 1.85e-03 | 109 | 46 | 3 | GO:0035383 | |
| GeneOntologyBiologicalProcess | acyl-CoA metabolic process | 1.85e-03 | 109 | 46 | 3 | GO:0006637 | |
| GeneOntologyBiologicalProcess | cochlea morphogenesis | 1.90e-03 | 29 | 46 | 2 | GO:0090103 | |
| GeneOntologyBiologicalProcess | protein autoprocessing | 2.03e-03 | 30 | 46 | 2 | GO:0016540 | |
| GeneOntologyBiologicalProcess | glycolytic process through fructose-6-phosphate | 2.17e-03 | 31 | 46 | 2 | GO:0061615 | |
| GeneOntologyBiologicalProcess | ribonucleotide biosynthetic process | 2.21e-03 | 247 | 46 | 4 | GO:0009260 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 2.27e-03 | 249 | 46 | 4 | GO:0010976 | |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | 2.41e-03 | 619 | 46 | 6 | GO:0006163 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | 2.41e-03 | 422 | 46 | 5 | GO:1990778 | |
| GeneOntologyBiologicalProcess | ribose phosphate biosynthetic process | 2.41e-03 | 253 | 46 | 4 | GO:0046390 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 2.76e-03 | 35 | 46 | 2 | GO:1901142 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 2.92e-03 | 36 | 46 | 2 | GO:0034694 | |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | 3.11e-03 | 652 | 46 | 6 | GO:0072521 | |
| GeneOntologyBiologicalProcess | neuron projection arborization | 3.25e-03 | 38 | 46 | 2 | GO:0140058 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 3.38e-03 | 663 | 46 | 6 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 3.41e-03 | 664 | 46 | 6 | GO:0099177 | |
| GeneOntologyBiologicalProcess | regulation of receptor localization to synapse | 3.42e-03 | 39 | 46 | 2 | GO:1902683 | |
| GeneOntologyBiologicalProcess | defense response to protozoan | 3.42e-03 | 39 | 46 | 2 | GO:0042832 | |
| GeneOntologyBiologicalProcess | purine nucleotide biosynthetic process | 3.47e-03 | 280 | 46 | 4 | GO:0006164 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | 3.56e-03 | 670 | 46 | 6 | GO:0120031 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 3.60e-03 | 40 | 46 | 2 | GO:1990806 | |
| GeneOntologyBiologicalProcess | regulation of long-term neuronal synaptic plasticity | 3.60e-03 | 40 | 46 | 2 | GO:0048169 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | 3.72e-03 | 1157 | 46 | 8 | GO:0006812 | |
| GeneOntologyBiologicalProcess | peptide hormone processing | 3.78e-03 | 41 | 46 | 2 | GO:0016486 | |
| GeneOntologyBiologicalProcess | startle response | 3.78e-03 | 41 | 46 | 2 | GO:0001964 | |
| GeneOntologyBiologicalProcess | purine-containing compound biosynthetic process | 3.83e-03 | 288 | 46 | 4 | GO:0072522 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate metabolic process | 3.91e-03 | 142 | 46 | 3 | GO:0034032 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate metabolic process | 3.91e-03 | 142 | 46 | 3 | GO:0033865 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate metabolic process | 3.91e-03 | 142 | 46 | 3 | GO:0033875 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | 3.94e-03 | 684 | 46 | 6 | GO:0009117 | |
| GeneOntologyBiologicalProcess | response to protozoan | 3.96e-03 | 42 | 46 | 2 | GO:0001562 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 4.16e-06 | 112 | 45 | 5 | GO:0055038 | |
| GeneOntologyCellularComponent | recycling endosome | 7.73e-06 | 222 | 45 | 6 | GO:0055037 | |
| GeneOntologyCellularComponent | tertiary granule membrane | 1.83e-05 | 73 | 45 | 4 | GO:0070821 | |
| GeneOntologyCellularComponent | tertiary granule | 2.65e-05 | 164 | 45 | 5 | GO:0070820 | |
| GeneOntologyCellularComponent | axon | 9.91e-05 | 891 | 45 | 9 | GO:0030424 | |
| GeneOntologyCellularComponent | cell body | 1.36e-04 | 929 | 45 | 9 | GO:0044297 | |
| GeneOntologyCellularComponent | secretory vesicle | 2.56e-04 | 1246 | 45 | 10 | GO:0099503 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | 3.76e-04 | 1307 | 45 | 10 | GO:0030659 | |
| GeneOntologyCellularComponent | vesicle membrane | 4.19e-04 | 1325 | 45 | 10 | GO:0012506 | |
| GeneOntologyCellularComponent | secretory granule membrane | 6.83e-04 | 329 | 45 | 5 | GO:0030667 | |
| GeneOntologyCellularComponent | anchoring junction | 1.01e-03 | 976 | 45 | 8 | GO:0070161 | |
| GeneOntologyCellularComponent | secretory granule | 1.30e-03 | 1014 | 45 | 8 | GO:0030141 | |
| GeneOntologyCellularComponent | perikaryon | 1.33e-03 | 223 | 45 | 4 | GO:0043204 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.48e-03 | 583 | 45 | 6 | GO:0097060 | |
| GeneOntologyCellularComponent | desmosome | 1.65e-03 | 28 | 45 | 2 | GO:0030057 | |
| GeneOntologyCellularComponent | endosome membrane | 1.74e-03 | 602 | 45 | 6 | GO:0010008 | |
| GeneOntologyCellularComponent | growth cone | 1.88e-03 | 245 | 45 | 4 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 2.11e-03 | 253 | 45 | 4 | GO:0030427 | |
| GeneOntologyCellularComponent | distal axon | 2.35e-03 | 435 | 45 | 5 | GO:0150034 | |
| GeneOntologyCellularComponent | presynapse | 2.67e-03 | 886 | 45 | 7 | GO:0098793 | |
| GeneOntologyCellularComponent | endosome | 3.13e-03 | 1167 | 45 | 8 | GO:0005768 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 4.23e-03 | 45 | 45 | 2 | GO:0008328 | |
| GeneOntologyCellularComponent | Golgi membrane | 4.27e-03 | 721 | 45 | 6 | GO:0000139 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 4.28e-03 | 1228 | 45 | 8 | GO:0036477 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 4.52e-03 | 155 | 45 | 3 | GO:0098685 | |
| GeneOntologyCellularComponent | transport vesicle | 4.99e-03 | 519 | 45 | 5 | GO:0030133 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 5.20e-03 | 50 | 45 | 2 | GO:0098878 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 6.73e-03 | 179 | 45 | 3 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 6.73e-03 | 179 | 45 | 3 | GO:0030672 | |
| HumanPheno | Linear nevus sebaceous | 8.04e-08 | 3 | 23 | 3 | HP:0010817 | |
| HumanPheno | Nevus sebaceous | 8.00e-07 | 5 | 23 | 3 | HP:0010815 | |
| HumanPheno | Congenital giant melanocytic nevus | 2.78e-06 | 7 | 23 | 3 | HP:0005600 | |
| HumanPheno | Hypophosphatemic rickets | 3.75e-06 | 25 | 23 | 4 | HP:0004912 | |
| HumanPheno | Melanocytic nevus | 1.02e-05 | 68 | 23 | 5 | HP:0000995 | |
| HumanPheno | Abnormal morphology of the vestibule of the inner ear | 1.19e-05 | 33 | 23 | 4 | HP:0011376 | |
| HumanPheno | Curly hair | 1.69e-05 | 36 | 23 | 4 | HP:0002212 | |
| HumanPheno | Epidermal nevus | 1.72e-05 | 12 | 23 | 3 | HP:0010816 | |
| HumanPheno | Hemimegalencephaly | 2.83e-05 | 14 | 23 | 3 | HP:0007206 | |
| HumanPheno | Rickets | 4.96e-05 | 47 | 23 | 4 | HP:0002748 | |
| HumanPheno | Cranial asymmetry | 5.25e-05 | 17 | 23 | 3 | HP:0000267 | |
| HumanPheno | Nevus spilus | 5.84e-05 | 3 | 23 | 2 | HP:0025510 | |
| HumanPheno | Aplasia of the semicircular canal | 6.28e-05 | 18 | 23 | 3 | HP:0011381 | |
| HumanPheno | Juvenile myelomonocytic leukemia | 6.28e-05 | 18 | 23 | 3 | HP:0012209 | |
| HumanPheno | Nevus | 7.96e-05 | 170 | 23 | 6 | HP:0003764 | |
| HumanPheno | Hypophosphatemia | 7.99e-05 | 53 | 23 | 4 | HP:0002148 | |
| HumanPheno | Abnormal iris pigmentation | 9.96e-05 | 355 | 23 | 8 | HP:0008034 | |
| HumanPheno | Cutaneous melanoma | 1.17e-04 | 22 | 23 | 3 | HP:0012056 | |
| HumanPheno | Thickened nuchal skin fold | 1.22e-04 | 59 | 23 | 4 | HP:0000474 | |
| HumanPheno | Delayed menarche | 1.34e-04 | 23 | 23 | 3 | HP:0012569 | |
| HumanPheno | Hypopigmentation of hair | 1.47e-04 | 276 | 23 | 7 | HP:0005599 | |
| HumanPheno | Ocular albinism | 1.47e-04 | 276 | 23 | 7 | HP:0001107 | |
| HumanPheno | Generalized hypopigmentation | 1.47e-04 | 276 | 23 | 7 | HP:0007513 | |
| HumanPheno | Albinism | 1.47e-04 | 276 | 23 | 7 | HP:0001022 | |
| HumanPheno | Hypopigmentation of the skin | 1.47e-04 | 276 | 23 | 7 | HP:0001010 | |
| HumanPheno | Abnormality of hair pigmentation | 1.61e-04 | 280 | 23 | 7 | HP:0009887 | |
| HumanPheno | Hemihypertrophy | 1.73e-04 | 25 | 23 | 3 | HP:0001528 | |
| HumanPheno | Adenoma sebaceum | 1.73e-04 | 25 | 23 | 3 | HP:0009720 | |
| HumanPheno | Abnormal semicircular canal morphology | 1.95e-04 | 26 | 23 | 3 | HP:0011380 | |
| HumanPheno | Iris hypopigmentation | 2.37e-04 | 298 | 23 | 7 | HP:0007730 | |
| HumanPheno | Abnormal lymphocyte apoptosis | 2.89e-04 | 6 | 23 | 2 | HP:0030886 | |
| HumanPheno | Non-medullary thyroid carcinoma | 2.89e-04 | 6 | 23 | 2 | HP:0040198 | |
| HumanPheno | Decreased lymphocyte apoptosis | 2.89e-04 | 6 | 23 | 2 | HP:0002731 | |
| HumanPheno | Abnormal blood phosphate concentration | 2.95e-04 | 74 | 23 | 4 | HP:0100529 | |
| HumanPheno | Angiofibromas | 3.02e-04 | 30 | 23 | 3 | HP:0010615 | |
| HumanPheno | Hyperphosphaturia | 3.02e-04 | 30 | 23 | 3 | HP:0003109 | |
| HumanPheno | Lymphedema | 3.27e-04 | 76 | 23 | 4 | HP:0001004 | |
| HumanPheno | Myeloid leukemia | 3.33e-04 | 31 | 23 | 3 | HP:0012324 | |
| HumanPheno | Cavernous hemangioma | 3.33e-04 | 31 | 23 | 3 | HP:0001048 | |
| HumanPheno | Transitional cell carcinoma of the bladder | 3.33e-04 | 31 | 23 | 3 | HP:0006740 | |
| HumanPheno | Porencephalic cyst | 3.66e-04 | 32 | 23 | 3 | HP:0002132 | |
| HumanPheno | Melanoma | 3.98e-04 | 80 | 23 | 4 | HP:0002861 | |
| HumanPheno | Bladder carcinoma | 4.02e-04 | 33 | 23 | 3 | HP:0002862 | |
| HumanPheno | Prominence of the premaxilla | 4.04e-04 | 7 | 23 | 2 | HP:0010759 | |
| HumanPheno | Abnormal inner ear morphology | 4.17e-04 | 81 | 23 | 4 | HP:0011390 | |
| HumanPheno | Genu recurvatum | 4.39e-04 | 34 | 23 | 3 | HP:0002816 | |
| HumanPheno | Abnormality of dental color | 4.39e-04 | 34 | 23 | 3 | HP:0011073 | |
| HumanPheno | Bladder neoplasm | 4.39e-04 | 34 | 23 | 3 | HP:0009725 | |
| HumanPheno | Abnormal urine phosphate concentration | 4.79e-04 | 35 | 23 | 3 | HP:0012599 | |
| HumanPheno | Aplasia/Hypoplasia of the abdominal wall musculature | 5.21e-04 | 36 | 23 | 3 | HP:0010318 | |
| HumanPheno | Prominent lips | 5.44e-04 | 156 | 23 | 5 | HP:0000184 | |
| HumanPheno | Overgrowth | 5.49e-04 | 87 | 23 | 4 | HP:0001548 | |
| HumanPheno | Hyperextensibility of the knee | 7.13e-04 | 40 | 23 | 3 | HP:0010500 | |
| HumanPheno | Enlarged thorax | 7.36e-04 | 94 | 23 | 4 | HP:0100625 | |
| HumanPheno | Megalencephaly | 9.44e-04 | 44 | 23 | 3 | HP:0001355 | |
| HumanPheno | Pectus carinatum | 9.92e-04 | 178 | 23 | 5 | HP:0000768 | |
| HumanPheno | Numerous nevi | 1.05e-03 | 11 | 23 | 2 | HP:0001054 | |
| HumanPheno | Thickened helices | 1.15e-03 | 47 | 23 | 3 | HP:0000391 | |
| HumanPheno | Abnormal urine anion concentration | 1.15e-03 | 47 | 23 | 3 | HP:0011866 | |
| HumanPheno | Abnormality of the premaxilla | 1.25e-03 | 12 | 23 | 2 | HP:0010758 | |
| HumanPheno | Fetal neck anomaly | 1.37e-03 | 111 | 23 | 4 | HP:0025667 | |
| HumanPheno | Kyphoscoliosis | 1.53e-03 | 196 | 23 | 5 | HP:0002751 | |
| HumanPheno | Cystic hygroma | 1.54e-03 | 52 | 23 | 3 | HP:0000476 | |
| HumanPheno | Blue irides | 1.72e-03 | 54 | 23 | 3 | HP:0000635 | |
| Domain | RAS | 1.59e-14 | 35 | 46 | 8 | PS51421 | |
| Domain | Small_GTPase_Ras | 2.61e-14 | 37 | 46 | 8 | IPR020849 | |
| Domain | Ras | 9.78e-13 | 136 | 46 | 10 | PF00071 | |
| Domain | Small_GTPase | 5.01e-12 | 160 | 46 | 10 | IPR001806 | |
| Domain | Small_GTP-bd_dom | 7.69e-12 | 167 | 46 | 10 | IPR005225 | |
| Domain | Dishevelled | 5.58e-08 | 4 | 46 | 3 | PF02377 | |
| Domain | Dishevelled_protein_dom | 5.58e-08 | 4 | 46 | 3 | IPR003351 | |
| Domain | Dishevelled_fam | 5.58e-08 | 4 | 46 | 3 | IPR008339 | |
| Domain | - | RIT1 HRAS KRAS RAB28 RAP2A RAP2B NRAS RAB14 RAP2C LSG1 RIT2 MYO1F | 1.68e-07 | 746 | 46 | 12 | 3.40.50.300 |
| Domain | DIX | 4.86e-07 | 7 | 46 | 3 | IPR001158 | |
| Domain | DIX | 4.86e-07 | 7 | 46 | 3 | PS50841 | |
| Domain | DAX | 4.86e-07 | 7 | 46 | 3 | SM00021 | |
| Domain | DIX | 4.86e-07 | 7 | 46 | 3 | PF00778 | |
| Domain | P-loop_NTPase | RIT1 HRAS KRAS RAB28 RAP2A RAP2B NRAS RAB14 RAP2C LSG1 RIT2 MYO1F | 6.63e-07 | 848 | 46 | 12 | IPR027417 |
| Domain | DVL-1 | 5.93e-06 | 2 | 46 | 2 | IPR008340 | |
| Domain | Dsh_C | 1.78e-05 | 3 | 46 | 2 | PF12316 | |
| Domain | Dishevelled_C-dom | 1.78e-05 | 3 | 46 | 2 | IPR024580 | |
| Domain | DEP | 2.08e-05 | 22 | 46 | 3 | PF00610 | |
| Domain | DEP | 2.08e-05 | 22 | 46 | 3 | SM00049 | |
| Domain | DEP | 2.08e-05 | 22 | 46 | 3 | PS50186 | |
| Domain | DEP_dom | 2.39e-05 | 23 | 46 | 3 | IPR000591 | |
| Domain | Dsh/Dvl-rel | 3.55e-05 | 4 | 46 | 2 | IPR015506 | |
| Domain | Peptidase_S8_Asp-AS | 8.85e-05 | 6 | 46 | 2 | IPR023827 | |
| Domain | PrprotnconvertsP | 1.24e-04 | 7 | 46 | 2 | IPR002884 | |
| Domain | P_proprotein | 1.24e-04 | 7 | 46 | 2 | PF01483 | |
| Domain | S8_pro-domain | 1.24e-04 | 7 | 46 | 2 | IPR032815 | |
| Domain | - | 1.24e-04 | 7 | 46 | 2 | 3.30.70.850 | |
| Domain | S8_pro-domain | 1.24e-04 | 7 | 46 | 2 | PF16470 | |
| Domain | Peptidase_S8_His-AS | 2.11e-04 | 9 | 46 | 2 | IPR022398 | |
| Domain | Peptidase_S8_Ser-AS | 2.11e-04 | 9 | 46 | 2 | IPR023828 | |
| Domain | Peptidase_S8_subtilisin-rel | 2.64e-04 | 10 | 46 | 2 | IPR015500 | |
| Domain | SUBTILASE_ASP | 2.64e-04 | 10 | 46 | 2 | PS00136 | |
| Domain | SUBTILASE_HIS | 2.64e-04 | 10 | 46 | 2 | PS00137 | |
| Domain | SUBTILASE_SER | 2.64e-04 | 10 | 46 | 2 | PS00138 | |
| Domain | Peptidase_S8 | 3.22e-04 | 11 | 46 | 2 | PF00082 | |
| Domain | - | 3.22e-04 | 11 | 46 | 2 | 3.40.50.200 | |
| Domain | Peptidase_S8/S53_dom | 3.22e-04 | 11 | 46 | 2 | IPR000209 | |
| Domain | PDZ | 3.97e-04 | 141 | 46 | 4 | PF00595 | |
| Domain | PDZ | 4.77e-04 | 148 | 46 | 4 | SM00228 | |
| Domain | PDZ | 5.15e-04 | 151 | 46 | 4 | PS50106 | |
| Domain | PDZ | 5.27e-04 | 152 | 46 | 4 | IPR001478 | |
| Domain | Propept_inh | 7.88e-04 | 17 | 46 | 2 | IPR009020 | |
| Domain | Iontro_rcpt | 8.85e-04 | 18 | 46 | 2 | IPR001320 | |
| Domain | Lig_chan | 8.85e-04 | 18 | 46 | 2 | PF00060 | |
| Domain | Lig_chan-Glu_bd | 8.85e-04 | 18 | 46 | 2 | PF10613 | |
| Domain | PBPe | 8.85e-04 | 18 | 46 | 2 | SM00079 | |
| Domain | Iono_rcpt_met | 8.85e-04 | 18 | 46 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 8.85e-04 | 18 | 46 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 8.85e-04 | 18 | 46 | 2 | SM00918 | |
| Domain | ANF_receptor | 3.74e-03 | 37 | 46 | 2 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 3.74e-03 | 37 | 46 | 2 | IPR001828 | |
| Domain | Pkinase_Tyr | 3.93e-03 | 129 | 46 | 3 | PF07714 | |
| Domain | Peripla_BP_I | 4.15e-03 | 39 | 46 | 2 | IPR028082 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 4.75e-03 | 138 | 46 | 3 | IPR001245 | |
| Domain | BTB-kelch_protein | 5.03e-03 | 43 | 46 | 2 | IPR017096 | |
| Domain | - | 5.99e-03 | 150 | 46 | 3 | 2.30.42.10 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX | 5.35e-10 | 6 | 36 | 4 | M47931 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.75e-08 | 12 | 36 | 4 | M47369 | |
| Pathway | PID_MAPK_TRK_PATHWAY | 2.15e-08 | 34 | 36 | 5 | M270 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 2.15e-08 | 34 | 36 | 5 | M13881 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 6.77e-08 | 85 | 36 | 6 | M48315 | |
| Pathway | REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS | 1.52e-07 | 5 | 36 | 3 | M26921 | |
| Pathway | KEGG_MELANOGENESIS | 1.91e-07 | 101 | 36 | 6 | M7761 | |
| Pathway | REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ | 3.04e-07 | 6 | 36 | 3 | M27951 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY | 3.04e-07 | 6 | 36 | 3 | M47433 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1 | 3.04e-07 | 6 | 36 | 3 | M47932 | |
| Pathway | PID_TRKR_PATHWAY | 4.37e-07 | 61 | 36 | 5 | M187 | |
| Pathway | REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS | 5.32e-07 | 7 | 36 | 3 | M29717 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 5.32e-07 | 7 | 36 | 3 | M19489 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP | 8.49e-07 | 8 | 36 | 3 | M47935 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS | 8.49e-07 | 8 | 36 | 3 | M27919 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 8.74e-07 | 70 | 36 | 5 | M3115 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 1.27e-06 | 9 | 36 | 3 | M27156 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 1.27e-06 | 9 | 36 | 3 | M27173 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS | 1.27e-06 | 9 | 36 | 3 | M27904 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 2.49e-06 | 11 | 36 | 3 | M27740 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE | 2.49e-06 | 11 | 36 | 3 | M27535 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 2.49e-06 | 11 | 36 | 3 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 2.49e-06 | 11 | 36 | 3 | M47371 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 2.49e-06 | 11 | 36 | 3 | M29814 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 2.49e-06 | 11 | 36 | 3 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 2.49e-06 | 11 | 36 | 3 | M47432 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 | 2.49e-06 | 11 | 36 | 3 | M27911 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 3.31e-06 | 12 | 36 | 3 | M47815 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 3.31e-06 | 12 | 36 | 3 | M29851 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 3.31e-06 | 12 | 36 | 3 | M39408 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 3.79e-06 | 94 | 36 | 5 | M2843 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 4.30e-06 | 13 | 36 | 3 | M47594 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 4.30e-06 | 13 | 36 | 3 | M1441 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 4.54e-06 | 270 | 36 | 7 | M15514 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 5.41e-06 | 46 | 36 | 4 | M39828 | |
| Pathway | REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES | 5.46e-06 | 14 | 36 | 3 | M27734 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 5.46e-06 | 14 | 36 | 3 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 5.46e-06 | 14 | 36 | 3 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 5.46e-06 | 14 | 36 | 3 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 5.46e-06 | 14 | 36 | 3 | M47390 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 5.46e-06 | 14 | 36 | 3 | M47378 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 5.46e-06 | 14 | 36 | 3 | M569 | |
| Pathway | PID_TCR_RAS_PATHWAY | 5.46e-06 | 14 | 36 | 3 | M134 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 5.46e-06 | 14 | 36 | 3 | M47488 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS | 5.46e-06 | 14 | 36 | 3 | M27908 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 5.46e-06 | 14 | 36 | 3 | M719 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII | 6.81e-06 | 15 | 36 | 3 | M29701 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47367 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47389 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47475 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 6.81e-06 | 15 | 36 | 3 | M47531 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 7.21e-06 | 411 | 36 | 8 | M735 | |
| Pathway | WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER | 7.59e-06 | 50 | 36 | 4 | M39822 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT | 8.21e-06 | 110 | 36 | 5 | M39492 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 8.37e-06 | 16 | 36 | 3 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 8.37e-06 | 16 | 36 | 3 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 8.37e-06 | 16 | 36 | 3 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 8.37e-06 | 16 | 36 | 3 | M47804 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 8.37e-06 | 16 | 36 | 3 | M47801 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 8.37e-06 | 16 | 36 | 3 | M562 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 8.37e-06 | 16 | 36 | 3 | M29847 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 8.37e-06 | 16 | 36 | 3 | M47483 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 8.37e-06 | 16 | 36 | 3 | M41733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY | 8.37e-06 | 16 | 36 | 3 | M47682 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.01e-05 | 17 | 36 | 3 | M47376 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY | 1.01e-05 | 17 | 36 | 3 | M47684 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK3_TRKC | 1.01e-05 | 17 | 36 | 3 | M27918 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.19e-05 | 205 | 36 | 6 | M752 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 1.22e-05 | 18 | 36 | 3 | M27518 | |
| Pathway | WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS | 1.22e-05 | 18 | 36 | 3 | M39737 | |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 1.22e-05 | 18 | 36 | 3 | M657 | |
| Pathway | REACTOME_TIE2_SIGNALING | 1.22e-05 | 18 | 36 | 3 | M11932 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY | 1.44e-05 | 19 | 36 | 3 | M47793 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS | 1.44e-05 | 19 | 36 | 3 | M559 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 1.44e-05 | 19 | 36 | 3 | M27423 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 1.44e-05 | 19 | 36 | 3 | M41732 | |
| Pathway | WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA | 1.47e-05 | 59 | 36 | 4 | M39750 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 1.69e-05 | 20 | 36 | 3 | M12256 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR3_SIGNALING | 1.69e-05 | 20 | 36 | 3 | M27519 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR4 | 1.69e-05 | 20 | 36 | 3 | M27524 | |
| Pathway | WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING | 1.69e-05 | 20 | 36 | 3 | M39485 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE | 1.69e-05 | 20 | 36 | 3 | M29849 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 1.69e-05 | 20 | 36 | 3 | M17670 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 1.69e-05 | 20 | 36 | 3 | M39002 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR1 | 1.97e-05 | 21 | 36 | 3 | M27511 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY | 1.97e-05 | 21 | 36 | 3 | M47792 | |
| Pubmed | The Ras branch of small GTPases: Ras family members don't fall far from the tree. | 1.08e-11 | 15 | 47 | 5 | 10712923 | |
| Pubmed | Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation. | 1.02e-10 | 7 | 47 | 4 | 35904492 | |
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 25788415 | ||
| Pubmed | Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules. | 2.31e-09 | 3 | 47 | 3 | 28116986 | |
| Pubmed | Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. | 2.31e-09 | 3 | 47 | 3 | 20090846 | |
| Pubmed | RAS gene mutations and histomorphometric measurements in oral squamous cell carcinoma. | 2.31e-09 | 3 | 47 | 3 | 37013448 | |
| Pubmed | Comparison of liver oncogenic potential among human RAS isoforms. | 2.31e-09 | 3 | 47 | 3 | 26799184 | |
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 21737741 | ||
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 31906952 | ||
| Pubmed | Partial functional overlap of the three ras genes in mouse embryonic development. | 2.31e-09 | 3 | 47 | 3 | 18059342 | |
| Pubmed | Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series. | 2.31e-09 | 3 | 47 | 3 | 23240926 | |
| Pubmed | Mutations of RAS gene family in specimens of bladder cancer. | 2.31e-09 | 3 | 47 | 3 | 19101897 | |
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 25977330 | ||
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 33620658 | ||
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 17943694 | ||
| Pubmed | Absolute Quantification of Endogenous Ras Isoform Abundance. | 2.31e-09 | 3 | 47 | 3 | 26560143 | |
| Pubmed | Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. | 2.31e-09 | 3 | 47 | 3 | 17712732 | |
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 24222113 | ||
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 28202657 | ||
| Pubmed | Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma. | 2.31e-09 | 3 | 47 | 3 | 16761621 | |
| Pubmed | Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. | 2.31e-09 | 3 | 47 | 3 | 22945650 | |
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 22589270 | ||
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 19303097 | ||
| Pubmed | A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. | 2.31e-09 | 3 | 47 | 3 | 23496764 | |
| Pubmed | Distribution of p21ras during primary palate formation of non-cleft and cleft strains of mice. | 2.31e-09 | 3 | 47 | 3 | 7776260 | |
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 27911734 | ||
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 28630043 | ||
| Pubmed | Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. | 2.31e-09 | 3 | 47 | 3 | 20150643 | |
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 20971740 | ||
| Pubmed | Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. | 2.31e-09 | 3 | 47 | 3 | 28259994 | |
| Pubmed | The variable phenotype and low-risk nature of RAS-positive thyroid nodules. | 2.31e-09 | 3 | 47 | 3 | 26253102 | |
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 16573741 | ||
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 27119512 | ||
| Pubmed | K-ras is an essential gene in the mouse with partial functional overlap with N-ras. | 2.31e-09 | 3 | 47 | 3 | 9334313 | |
| Pubmed | Rap2, but not Rap1 GTPase is expressed in human red blood cells and is involved in vesiculation. | 9.24e-09 | 4 | 47 | 3 | 16540189 | |
| Pubmed | 9.24e-09 | 4 | 47 | 3 | 8817329 | ||
| Pubmed | Human dishevelled genes constitute a DHR-containing multigene family. | 9.24e-09 | 4 | 47 | 3 | 9192851 | |
| Pubmed | The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions. | 9.24e-09 | 4 | 47 | 3 | 27936046 | |
| Pubmed | 9.24e-09 | 4 | 47 | 3 | 10085069 | ||
| Pubmed | 9.24e-09 | 4 | 47 | 3 | 38849523 | ||
| Pubmed | Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury. | 9.24e-09 | 4 | 47 | 3 | 29502968 | |
| Pubmed | 9.24e-09 | 4 | 47 | 3 | 34948093 | ||
| Pubmed | 9.24e-09 | 4 | 47 | 3 | 9674433 | ||
| Pubmed | Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. | 9.24e-09 | 4 | 47 | 3 | 7972015 | |
| Pubmed | 9.24e-09 | 4 | 47 | 3 | 10490827 | ||
| Pubmed | Ras membrane orientation and nanodomain localization generate isoform diversity. | 9.24e-09 | 4 | 47 | 3 | 20080631 | |
| Pubmed | Quantification of spatiotemporal patterns of Ras isoform expression during development. | 9.24e-09 | 4 | 47 | 3 | 28117393 | |
| Pubmed | Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding. | 9.24e-09 | 4 | 47 | 3 | 25999467 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 9069260 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 22982107 | ||
| Pubmed | Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis. | 2.31e-08 | 5 | 47 | 3 | 24746824 | |
| Pubmed | Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions. | 2.31e-08 | 5 | 47 | 3 | 34535655 | |
| Pubmed | Activated Ras induces lens epithelial cell hyperplasia but not premature differentiation. | 2.31e-08 | 5 | 47 | 3 | 15558479 | |
| Pubmed | Ubiquitylation by Rab40b/Cul5 regulates Rap2 localization and activity during cell migration. | 2.31e-08 | 5 | 47 | 3 | 35293963 | |
| Pubmed | Focused molecular analysis of small cell lung cancer: feasibility in routine clinical practice. | 2.31e-08 | 5 | 47 | 3 | 26581482 | |
| Pubmed | A novel RalGEF-like protein, RGL3, as a candidate effector for rit and Ras. | 2.31e-08 | 5 | 47 | 3 | 10869344 | |
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 21072204 | ||
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 9753431 | ||
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 10882715 | ||
| Pubmed | Glutamate transporter Slc1a3 mediates inter-niche stem cell activation during skin growth. | 4.61e-08 | 6 | 47 | 3 | 29615452 | |
| Pubmed | LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases. | 4.61e-08 | 6 | 47 | 3 | 31337872 | |
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 19487299 | ||
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 20526288 | ||
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 20179099 | ||
| Pubmed | SmgGDS displays differential binding and exchange activity towards different Ras isoforms. | 8.06e-08 | 7 | 47 | 3 | 11948427 | |
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 20860430 | ||
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 20012784 | ||
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 22199277 | ||
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 9690470 | ||
| Pubmed | 1.29e-07 | 8 | 47 | 3 | 15064703 | ||
| Pubmed | Biochemical characterization of the Ras-related GTPases Rit and Rin. | 1.29e-07 | 8 | 47 | 3 | 10545207 | |
| Pubmed | Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival. | 1.29e-07 | 8 | 47 | 3 | 20150892 | |
| Pubmed | 1.93e-07 | 9 | 47 | 3 | 10783161 | ||
| Pubmed | 1.93e-07 | 9 | 47 | 3 | 9344703 | ||
| Pubmed | 1.93e-07 | 9 | 47 | 3 | 11857081 | ||
| Pubmed | 2.76e-07 | 10 | 47 | 3 | 15451670 | ||
| Pubmed | 2.76e-07 | 10 | 47 | 3 | 34215617 | ||
| Pubmed | Desmoplakin maintains gap junctions by inhibiting Ras/MAPK and lysosomal degradation of connexin-43. | 2.76e-07 | 10 | 47 | 3 | 29959233 | |
| Pubmed | SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras. | 3.79e-07 | 11 | 47 | 3 | 28263956 | |
| Pubmed | 3.79e-07 | 11 | 47 | 3 | 11786539 | ||
| Pubmed | 5.05e-07 | 12 | 47 | 3 | 9269777 | ||
| Pubmed | Ras effectors and their role in mitogenesis and oncogenesis. | 5.05e-07 | 12 | 47 | 3 | 9297626 | |
| Pubmed | 8.33e-07 | 14 | 47 | 3 | 25359213 | ||
| Pubmed | 8.33e-07 | 14 | 47 | 3 | 1354647 | ||
| Pubmed | Rap2A links intestinal cell polarity to brush border formation. | 1.04e-06 | 15 | 47 | 3 | 22797597 | |
| Pubmed | 1.04e-06 | 15 | 47 | 3 | 20301303 | ||
| Pubmed | 1.04e-06 | 15 | 47 | 3 | 23831572 | ||
| Pubmed | Novel RFLPs at protooncogene and cancer-related gene loci on mouse chromosomes. | 1.28e-06 | 16 | 47 | 3 | 8095010 | |
| Pubmed | Mechanism of activation of an N-ras gene in the human fibrosarcoma cell line HT1080. | 1.79e-06 | 2 | 47 | 2 | 6086315 | |
| Pubmed | Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis. | 1.79e-06 | 2 | 47 | 2 | 10871846 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 19789336 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 14614908 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 30860980 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 16624289 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 27698462 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 16293189 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 34117033 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 22407852 | ||
| Pubmed | Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck. | 1.79e-06 | 2 | 47 | 2 | 31960612 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24018645 | ||
| Interaction | RALGDS interactions | 2.13e-10 | 36 | 47 | 6 | int:RALGDS | |
| Interaction | RGL1 interactions | 4.64e-10 | 18 | 47 | 5 | int:RGL1 | |
| Interaction | RAPGEF6 interactions | 2.62e-08 | 78 | 47 | 6 | int:RAPGEF6 | |
| Interaction | RAP1GDS1 interactions | 3.52e-08 | 141 | 47 | 7 | int:RAP1GDS1 | |
| Interaction | ELMOD3 interactions | 4.63e-08 | 16 | 47 | 4 | int:ELMOD3 | |
| Interaction | MAP4K4 interactions | 1.17e-07 | 254 | 47 | 8 | int:MAP4K4 | |
| Interaction | RASSF5 interactions | 1.33e-07 | 52 | 47 | 5 | int:RASSF5 | |
| Interaction | NSF interactions | 1.58e-07 | 264 | 47 | 8 | int:NSF | |
| Interaction | RAP2C interactions | 1.77e-07 | 55 | 47 | 5 | int:RAP2C | |
| Interaction | RABGGTB interactions | 1.85e-07 | 108 | 47 | 6 | int:RABGGTB | |
| Interaction | HEPH interactions | 2.37e-07 | 6 | 47 | 3 | int:HEPH | |
| Interaction | CENPN interactions | 3.25e-07 | 62 | 47 | 5 | int:CENPN | |
| Interaction | PDLIM4 interactions | 4.38e-07 | 27 | 47 | 4 | int:PDLIM4 | |
| Interaction | CHMP6 interactions | 1.01e-06 | 33 | 47 | 4 | int:CHMP6 | |
| Interaction | TRPV2 interactions | 1.41e-06 | 10 | 47 | 3 | int:TRPV2 | |
| Interaction | DLGAP4 interactions | 1.49e-06 | 84 | 47 | 5 | int:DLGAP4 | |
| Interaction | UNC5B interactions | 1.49e-06 | 84 | 47 | 5 | int:UNC5B | |
| Interaction | RHEB interactions | 2.16e-06 | 164 | 47 | 6 | int:RHEB | |
| Interaction | GTSF1 interactions | 2.58e-06 | 12 | 47 | 3 | int:GTSF1 | |
| Interaction | SLCO4A1 interactions | 3.94e-06 | 46 | 47 | 4 | int:SLCO4A1 | |
| Interaction | ITGB6 interactions | 4.25e-06 | 14 | 47 | 3 | int:ITGB6 | |
| Interaction | RGL3 interactions | 5.53e-06 | 50 | 47 | 4 | int:RGL3 | |
| Interaction | LZTR1 interactions | 5.91e-06 | 111 | 47 | 5 | int:LZTR1 | |
| Interaction | SAMSN1 interactions | 6.52e-06 | 16 | 47 | 3 | int:SAMSN1 | |
| Interaction | GALE interactions | 6.99e-06 | 53 | 47 | 4 | int:GALE | |
| Interaction | NUMBL interactions | 7.33e-06 | 116 | 47 | 5 | int:NUMBL | |
| Interaction | RALGPS2 interactions | 7.54e-06 | 54 | 47 | 4 | int:RALGPS2 | |
| Interaction | SOS1 interactions | 7.64e-06 | 117 | 47 | 5 | int:SOS1 | |
| Interaction | GYPC interactions | 1.12e-05 | 19 | 47 | 3 | int:GYPC | |
| Interaction | AFDN interactions | 1.13e-05 | 333 | 47 | 7 | int:AFDN | |
| Interaction | MARVELD2 interactions | 1.15e-05 | 60 | 47 | 4 | int:MARVELD2 | |
| Interaction | SLC12A4 interactions | 1.23e-05 | 129 | 47 | 5 | int:SLC12A4 | |
| Interaction | CSNK1G3 interactions | 1.28e-05 | 130 | 47 | 5 | int:CSNK1G3 | |
| Interaction | SEPTIN5 interactions | 1.31e-05 | 62 | 47 | 4 | int:SEPTIN5 | |
| Interaction | SUSD5 interactions | 1.32e-05 | 20 | 47 | 3 | int:SUSD5 | |
| Interaction | SLC6A9 interactions | 1.32e-05 | 20 | 47 | 3 | int:SLC6A9 | |
| Interaction | DLG3 interactions | 1.32e-05 | 131 | 47 | 5 | int:DLG3 | |
| Interaction | RIT2 interactions | 1.54e-05 | 21 | 47 | 3 | int:RIT2 | |
| Interaction | NUMB interactions | 1.58e-05 | 232 | 47 | 6 | int:NUMB | |
| Interaction | PKP3 interactions | 1.59e-05 | 136 | 47 | 5 | int:PKP3 | |
| Interaction | FAM72C interactions | 1.59e-05 | 3 | 47 | 2 | int:FAM72C | |
| Interaction | PDE6D interactions | 1.68e-05 | 66 | 47 | 4 | int:PDE6D | |
| Interaction | NECTIN1 interactions | 1.77e-05 | 22 | 47 | 3 | int:NECTIN1 | |
| Interaction | ICMT interactions | 1.79e-05 | 67 | 47 | 4 | int:ICMT | |
| Interaction | CENPM interactions | 1.96e-05 | 142 | 47 | 5 | int:CENPM | |
| Interaction | DPH5 interactions | 2.04e-05 | 23 | 47 | 3 | int:DPH5 | |
| Interaction | SLC23A2 interactions | 2.04e-05 | 23 | 47 | 3 | int:SLC23A2 | |
| Interaction | PTPRM interactions | 2.38e-05 | 72 | 47 | 4 | int:PTPRM | |
| Interaction | ARHGAP29 interactions | 2.65e-05 | 74 | 47 | 4 | int:ARHGAP29 | |
| Interaction | SHOC2 interactions | 2.65e-05 | 74 | 47 | 4 | int:SHOC2 | |
| Interaction | FREM1 interactions | 3.18e-05 | 4 | 47 | 2 | int:FREM1 | |
| Interaction | TBC1D3H interactions | 3.18e-05 | 4 | 47 | 2 | int:TBC1D3H | |
| Interaction | TBC1D3D interactions | 3.18e-05 | 4 | 47 | 2 | int:TBC1D3D | |
| Interaction | ALG1L2 interactions | 3.18e-05 | 4 | 47 | 2 | int:ALG1L2 | |
| Interaction | NEDD4 interactions | 3.33e-05 | 544 | 47 | 8 | int:NEDD4 | |
| Interaction | ERBIN interactions | 3.34e-05 | 265 | 47 | 6 | int:ERBIN | |
| Interaction | ITGB1 interactions | 3.65e-05 | 400 | 47 | 7 | int:ITGB1 | |
| Interaction | RGL2 interactions | 3.74e-05 | 28 | 47 | 3 | int:RGL2 | |
| Interaction | DHODH interactions | 3.79e-05 | 81 | 47 | 4 | int:DHODH | |
| Interaction | SPOUT1 interactions | 3.79e-05 | 163 | 47 | 5 | int:SPOUT1 | |
| Interaction | SLC35A2 interactions | 4.16e-05 | 29 | 47 | 3 | int:SLC35A2 | |
| Interaction | DCUN1D3 interactions | 4.16e-05 | 29 | 47 | 3 | int:DCUN1D3 | |
| Interaction | YRDC interactions | 4.16e-05 | 29 | 47 | 3 | int:YRDC | |
| Interaction | CSPG4 interactions | 4.37e-05 | 84 | 47 | 4 | int:CSPG4 | |
| Interaction | PLEKHO1 interactions | 4.37e-05 | 84 | 47 | 4 | int:PLEKHO1 | |
| Interaction | SLC1A4 interactions | 4.62e-05 | 30 | 47 | 3 | int:SLC1A4 | |
| Interaction | CD276 interactions | 4.62e-05 | 30 | 47 | 3 | int:CD276 | |
| Interaction | JAM3 interactions | 5.10e-05 | 31 | 47 | 3 | int:JAM3 | |
| Interaction | ANO10 interactions | 5.10e-05 | 31 | 47 | 3 | int:ANO10 | |
| Interaction | DCBLD1 interactions | 5.10e-05 | 31 | 47 | 3 | int:DCBLD1 | |
| Interaction | PRELID1 interactions | 5.10e-05 | 31 | 47 | 3 | int:PRELID1 | |
| Interaction | NAA20 interactions | 5.10e-05 | 31 | 47 | 3 | int:NAA20 | |
| Interaction | SLITRK2 interactions | 5.30e-05 | 5 | 47 | 2 | int:SLITRK2 | |
| Interaction | LRRC37A interactions | 5.30e-05 | 5 | 47 | 2 | int:LRRC37A | |
| Interaction | PPIAL4E interactions | 5.30e-05 | 5 | 47 | 2 | int:PPIAL4E | |
| Interaction | GOLGA6L1 interactions | 5.30e-05 | 5 | 47 | 2 | int:GOLGA6L1 | |
| Interaction | NPIPA1 interactions | 5.30e-05 | 5 | 47 | 2 | int:NPIPA1 | |
| Interaction | NBPF20 interactions | 5.30e-05 | 5 | 47 | 2 | int:NBPF20 | |
| Interaction | PET117 interactions | 5.30e-05 | 5 | 47 | 2 | int:PET117 | |
| Interaction | DVL1P1 interactions | 5.30e-05 | 5 | 47 | 2 | int:DVL1P1 | |
| Interaction | GOLGA8K interactions | 5.30e-05 | 5 | 47 | 2 | int:GOLGA8K | |
| Interaction | MEAK7 interactions | 5.62e-05 | 32 | 47 | 3 | int:MEAK7 | |
| Interaction | KIAA0319L interactions | 5.73e-05 | 90 | 47 | 4 | int:KIAA0319L | |
| Interaction | ABCE1 interactions | 5.86e-05 | 431 | 47 | 7 | int:ABCE1 | |
| Interaction | FPGS interactions | 6.18e-05 | 33 | 47 | 3 | int:FPGS | |
| Interaction | RAB40B interactions | 6.18e-05 | 33 | 47 | 3 | int:RAB40B | |
| Interaction | SBDS interactions | 6.25e-05 | 181 | 47 | 5 | int:SBDS | |
| Interaction | RAB11FIP5 interactions | 7.29e-05 | 187 | 47 | 5 | int:RAB11FIP5 | |
| Interaction | HYCC1 interactions | 7.38e-05 | 35 | 47 | 3 | int:HYCC1 | |
| Interaction | LRRC57 interactions | 7.38e-05 | 35 | 47 | 3 | int:LRRC57 | |
| Interaction | SLC2A3 interactions | 7.38e-05 | 35 | 47 | 3 | int:SLC2A3 | |
| Interaction | SNRNP25 interactions | 7.38e-05 | 35 | 47 | 3 | int:SNRNP25 | |
| Interaction | ATP6AP2 interactions | 7.42e-05 | 306 | 47 | 6 | int:ATP6AP2 | |
| Interaction | PIK3CA interactions | 7.48e-05 | 188 | 47 | 5 | int:PIK3CA | |
| Interaction | SLC33A1 interactions | 7.67e-05 | 189 | 47 | 5 | int:SLC33A1 | |
| Interaction | CLCC1 interactions | 7.86e-05 | 190 | 47 | 5 | int:CLCC1 | |
| Interaction | LRRC37A3 interactions | 7.94e-05 | 6 | 47 | 2 | int:LRRC37A3 | |
| Interaction | NBPF14 interactions | 7.94e-05 | 6 | 47 | 2 | int:NBPF14 | |
| Interaction | TBC1D3K interactions | 7.94e-05 | 6 | 47 | 2 | int:TBC1D3K | |
| Interaction | AGAP11 interactions | 7.94e-05 | 6 | 47 | 2 | int:AGAP11 | |
| GeneFamily | RAS type GTPase family | 1.32e-15 | 31 | 38 | 8 | 389 | |
| GeneFamily | Dishevelled segment polarity proteins|PDZ domain containing | 2.57e-05 | 4 | 38 | 2 | 505 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 1.53e-04 | 9 | 38 | 2 | 973 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.19e-03 | 40 | 38 | 2 | 321 | |
| GeneFamily | Kelch like|BTB domain containing | 3.51e-03 | 42 | 38 | 2 | 617 | |
| GeneFamily | PDZ domain containing | 3.96e-03 | 152 | 38 | 3 | 1220 | |
| GeneFamily | RAB, member RAS oncogene GTPases | 8.23e-03 | 65 | 38 | 2 | 388 | |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP | 2.04e-05 | 190 | 46 | 5 | M18436 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | 2.62e-05 | 200 | 46 | 5 | M5063 | |
| Coexpression | GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN | 2.62e-05 | 200 | 46 | 5 | M6556 | |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN | 2.62e-05 | 200 | 46 | 5 | M6554 | |
| Coexpression | GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN | 2.62e-05 | 200 | 46 | 5 | M7372 | |
| Coexpression | HALLMARK_PI3K_AKT_MTOR_SIGNALING | 3.49e-05 | 105 | 46 | 4 | M5923 | |
| Coexpression | DING_LUNG_CANCER_MUTATED_RECURRENTLY | 4.50e-05 | 6 | 46 | 2 | M14019 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP | 6.11e-05 | 239 | 46 | 5 | M1570 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP | 7.27e-05 | 248 | 46 | 5 | MM1116 | |
| Coexpression | KAAB_HEART_ATRIUM_VS_VENTRICLE_UP | 8.45e-05 | 256 | 46 | 5 | M10952 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.45e-06 | 184 | 47 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 1.78e-06 | 192 | 47 | 5 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.87e-06 | 194 | 47 | 5 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.92e-06 | 195 | 47 | 5 | b0cea3f4e59635913d243612f2e8cf4c7b34e726 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-06 | 198 | 47 | 5 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.62e-05 | 163 | 47 | 4 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 164 | 47 | 4 | a187bd5beca017ef657ef07c006e7f94ea3b911b | |
| ToppCell | COVID-19_Convalescent-PLT_1|World / Disease Group and Platelet Clusters | 3.78e-05 | 179 | 47 | 4 | d0f2764c6fc5d61fd69e9231b3603a80ac373f65 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.86e-05 | 180 | 47 | 4 | e4add4c94f892a2d93926e5c6dac6a738319d091 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-05 | 182 | 47 | 4 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.12e-05 | 183 | 47 | 4 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.21e-05 | 184 | 47 | 4 | 3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.21e-05 | 184 | 47 | 4 | 6e17c8151d6dc543de16d804db956c63c3fda414 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.21e-05 | 184 | 47 | 4 | 1e2f0cec50475a1cf2973a5082826bbc60fc9a68 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.21e-05 | 184 | 47 | 4 | 8880ff36c243cc60a524d74934d000aef26a70ac | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.58e-05 | 188 | 47 | 4 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 4.58e-05 | 188 | 47 | 4 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | 18-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class | 4.67e-05 | 189 | 47 | 4 | 144beb01b908f2cd0e04513fb84d817e0c3c124e | |
| ToppCell | (7)_Epithelial-D_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.77e-05 | 190 | 47 | 4 | 832d6d3ad14665e50623afe1b8586ccae1a97de5 | |
| ToppCell | AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 4.77e-05 | 190 | 47 | 4 | 46dfab02c1b4a403b7efc871707b6a189eefd4c4 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.77e-05 | 190 | 47 | 4 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.87e-05 | 191 | 47 | 4 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 4.87e-05 | 191 | 47 | 4 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | 15-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 4.87e-05 | 191 | 47 | 4 | 76311fa5f3ae9bb27cf04387a8c92300f2888c28 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.97e-05 | 192 | 47 | 4 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 4.97e-05 | 192 | 47 | 4 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 5.07e-05 | 193 | 47 | 4 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | AT2|World / shred by cell class for parenchyma | 5.17e-05 | 194 | 47 | 4 | e773f5ef3abce7113a6b7cc7cbe68de873d4a17f | |
| ToppCell | Differ-Basal|World / shred by cell class for mouse tongue | 5.17e-05 | 194 | 47 | 4 | 851eff82c9f3d44c86e3e127a804bbd1fced6a7c | |
| ToppCell | ASK428|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.27e-05 | 195 | 47 | 4 | 41cbd7ea0bfab2db338b4ba0fc67cb3ae0d63d6d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.27e-05 | 195 | 47 | 4 | 6617abca0009ad3d8731f515f91ab275f9ea4c40 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.27e-05 | 195 | 47 | 4 | fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.38e-05 | 196 | 47 | 4 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.38e-05 | 196 | 47 | 4 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.49e-05 | 197 | 47 | 4 | 3a0e97bfebe82f9687d518baaad7f20d0ffea8a1 | |
| ToppCell | T_cells-CTLs|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.49e-05 | 197 | 47 | 4 | 28117cf300e169182571fbad0de1681a484a435a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.60e-05 | 198 | 47 | 4 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.71e-05 | 199 | 47 | 4 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.71e-05 | 199 | 47 | 4 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.71e-05 | 199 | 47 | 4 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.71e-05 | 199 | 47 | 4 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuroepithelial|1m / Sample Type, Dataset, Time_group, and Cell type. | 5.82e-05 | 200 | 47 | 4 | fe15fb050852c187f6f17fb4f6172e69fe7d74a4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuroepithelial-Proteoglycan-expressing_cell|1m / Sample Type, Dataset, Time_group, and Cell type. | 5.82e-05 | 200 | 47 | 4 | d0a4c3bf9c5211defb4c1d0b6653833cccbd29ee | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.82e-05 | 200 | 47 | 4 | 65c83a3f6ee2a10bcb5b95076696232c6373a7b4 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.82e-05 | 200 | 47 | 4 | 40e969883bc302e8fbc6b6ab9814529dc1472902 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.82e-05 | 200 | 47 | 4 | ad9cdc82a647d379abc713a56db0e11bb6494106 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-neuroepithelial-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.25e-04 | 127 | 47 | 3 | 9071cd0953c8bb6746dc9cd13d153e3d6ef40b08 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-5|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.24e-04 | 139 | 47 | 3 | 849e4c060c9cf9eb7962caf5b169e72da4d85e70 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.29e-04 | 150 | 47 | 3 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-04 | 154 | 47 | 3 | 5ed64bbf603290e6dc34f81d145982690b89dd0d | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-04 | 157 | 47 | 3 | d85a2f56ae313baa9738e81d2756ce1fe1ba50db | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.27e-04 | 159 | 47 | 3 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.38e-04 | 160 | 47 | 3 | 237430af14830b38e58da8a4224036e5c6b71c5b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.38e-04 | 160 | 47 | 3 | 778faada072e3abfa76a9a06fd4885fb63de7902 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.85e-04 | 164 | 47 | 3 | beaa13a75c3bb72446c85084d75e9fe3f15fd3d4 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.85e-04 | 164 | 47 | 3 | d005cfd821b87548b075120bffe65a0be9860463 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.22e-04 | 167 | 47 | 3 | 49b19159c62d33d65ed1e59a148c11ae902fd41c | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-04 | 168 | 47 | 3 | 74dc46738f1d0a448df6c9b8288b515d92697792 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.35e-04 | 168 | 47 | 3 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | severe-Myeloid-mDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.35e-04 | 168 | 47 | 3 | eff37a92d41624924201372cc09f9eb07b60aec1 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.48e-04 | 169 | 47 | 3 | a83e4078db91ecedee637b28b12ec38640fe45f9 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.48e-04 | 169 | 47 | 3 | d9c3b22f62b882b8a2ea6fd9cf7afbe6d1775745 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-maDC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.48e-04 | 169 | 47 | 3 | f914aa8899fa170a09da31e5fad86de897ea789b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 7.61e-04 | 170 | 47 | 3 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.61e-04 | 170 | 47 | 3 | 941d637cf76918ee4b0a1833abd1a42593cb8b1a | |
| ToppCell | T_cells-GNLY+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.74e-04 | 171 | 47 | 3 | 04c811817cfec45af5f2891793106cc7ddb0300e | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-04 | 173 | 47 | 3 | 6e92983d9f8a2a37f23e60a0d5bb1738217897bc | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 8.00e-04 | 173 | 47 | 3 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-04 | 173 | 47 | 3 | 4c788c1dad1da495b3b5c10f95e779848dfe85dc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.00e-04 | 173 | 47 | 3 | d17e50dc400098374af626803dec1241ec566769 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.13e-04 | 174 | 47 | 3 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.13e-04 | 174 | 47 | 3 | a62531ebf16b32b249168dca11b870f63a8aa81c | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-04 | 175 | 47 | 3 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.27e-04 | 175 | 47 | 3 | 19eda8b5d39dc93d79737ebdbeeba5ec0cb23c51 | |
| ToppCell | COVID-19_Convalescent|World / Disease Group and Platelet Clusters | 8.27e-04 | 175 | 47 | 3 | e9b1faa4c85537f30306619a2f3ada6c8ef0ac6c | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.27e-04 | 175 | 47 | 3 | 21f8f11a8b874d4f7c47931010a2535f2a5a3373 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.27e-04 | 175 | 47 | 3 | ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-Alox5+_lymphocyte-Alox5+_lymphocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.55e-04 | 177 | 47 | 3 | b7cfa3776f58377e35830780650d236b5cceecee | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-Alox5+_lymphocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.55e-04 | 177 | 47 | 3 | 1730e640986e50943bd781b7d949bcc5b7c12dde | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.55e-04 | 177 | 47 | 3 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.69e-04 | 178 | 47 | 3 | 38ffbd01230c99f52274424ee6c172381daffc73 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.83e-04 | 179 | 47 | 3 | df6d2cdc4e204ce1a4628dc71dfbc5e6c6309b2a | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Lymphocytic-T_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-04 | 179 | 47 | 3 | 48ee1c6d6402c7f5d6578f8de14da6f55aa952d6 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-04 | 180 | 47 | 3 | 67b062f2ef7e20f392e00c646f4985c415d40de9 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.97e-04 | 180 | 47 | 3 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-04 | 180 | 47 | 3 | b28363626f4d2a552abde3434cc1df2e2121aba5 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Lymphocytic-T_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-04 | 180 | 47 | 3 | 7bdc040461f350dd3136219341b39679fbca317e | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 8.97e-04 | 180 | 47 | 3 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.12e-04 | 181 | 47 | 3 | 092a971661b0aa06c1cdf428dbfa7339a26fb678 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.12e-04 | 181 | 47 | 3 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 9.26e-04 | 182 | 47 | 3 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.26e-04 | 182 | 47 | 3 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.26e-04 | 182 | 47 | 3 | 1923932a9c60e9ec33db69ded441210d1fb07bec | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.26e-04 | 182 | 47 | 3 | 69ff652f74cc47fbe0bd665ab17c445c5b959dad | |
| ToppCell | wk_15-18-Epithelial-PNS-Early_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.41e-04 | 183 | 47 | 3 | 7e8366ec8117d36cec67f77dcb0e9a6032d87fcb | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.41e-04 | 183 | 47 | 3 | f517215ff45dec914af52dfdbc4579c19654c3aa | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.41e-04 | 183 | 47 | 3 | e0854864d377e158a4793088d1cb6b3dbf2c805d | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-04 | 183 | 47 | 3 | 2cf36ad89584eb9f8b04de52a1b511b7f3527884 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-04 | 183 | 47 | 3 | 98fee6838acfaee5e2e449ba088764ec06b8bc57 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.56e-04 | 184 | 47 | 3 | e0e5a553fb8c0947679634396d20c2ca8455b932 | |
| Computational | Small monomeric GTPases. | 9.44e-06 | 43 | 34 | 4 | MODULE_86 | |
| Computational | Genes in the cancer module 87. | 3.50e-04 | 44 | 34 | 3 | MODULE_87 | |
| Drug | AC1L32OA | 1.82e-09 | 9 | 46 | 4 | CID000107745 | |
| Drug | L 744832 | 3.08e-08 | 4 | 46 | 3 | ctd:C096898 | |
| Drug | guanine | RIT1 HRAS KRAS GRIA2 RAP2A RAP2B GRIN2C NRAS RAP2C ENO1 ADCY6 RIT2 | 1.56e-07 | 902 | 46 | 12 | CID000000764 |
| Drug | Monensin sodium salt [22373-78-0]; Up 200; 5.8uM; PC3; HT_HG-U133A | 1.90e-06 | 185 | 46 | 6 | 7402_UP | |
| Drug | isoprene | 3.99e-06 | 2 | 46 | 2 | ctd:C005059 | |
| Drug | AC1L9LT0 | 4.87e-06 | 123 | 46 | 5 | CID000448294 | |
| Drug | Tetranitromethane | 1.20e-05 | 3 | 46 | 2 | ctd:D013774 | |
| Drug | GGTI 2147 | 1.20e-05 | 3 | 46 | 2 | ctd:C466792 | |
| Drug | AC1L1E5T | 1.51e-05 | 74 | 46 | 4 | CID000002653 | |
| Drug | AC1L1JND | 1.96e-05 | 79 | 46 | 4 | CID000005118 | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.48e-05 | 172 | 46 | 5 | 1017_UP | |
| Drug | mevalonolactone | 3.98e-05 | 5 | 46 | 2 | ctd:C015367 | |
| Drug | Actinomycin C2 | 3.98e-05 | 5 | 46 | 2 | CID000122716 | |
| Drug | dopamine quinone | 3.98e-05 | 5 | 46 | 2 | ctd:C104705 | |
| Drug | Guanosine-5'-Triphosphate | 3.98e-05 | 5 | 46 | 2 | DB04137 | |
| Drug | guanosine 5'-diphosphate disodium salt | 4.14e-05 | 648 | 46 | 8 | CID000000730 | |
| Drug | C75; Down 200; 10uM; MCF7; HT_HG-U133A | 4.30e-05 | 193 | 46 | 5 | 6394_DN | |
| Drug | Zidovudine, AZT [30516-87-1]; Up 200; 15uM; PC3; HT_HG-U133A | 4.30e-05 | 193 | 46 | 5 | 6733_UP | |
| Drug | LY294002; Up 200; 10uM; MCF7; HT_HG-U133A | 4.30e-05 | 193 | 46 | 5 | 5965_UP | |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Up 200; 9uM; PC3; HT_HG-U133A | 4.40e-05 | 194 | 46 | 5 | 7399_UP | |
| Drug | homovanillic acid | 4.40e-05 | 97 | 46 | 4 | CID000001738 | |
| Drug | Dequalinium dichloride [522-51-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 4.62e-05 | 196 | 46 | 5 | 2631_UP | |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 5262_UP | |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; PC3; HT_HG-U133A | 4.85e-05 | 198 | 46 | 5 | 6742_UP | |
| Drug | Arcaine sulfate [14923-17-2]; Up 200; 14.8uM; PC3; HT_HG-U133A | 4.97e-05 | 199 | 46 | 5 | 6629_UP | |
| Drug | Condelphine [7633-69-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | 4.97e-05 | 199 | 46 | 5 | 6357_UP | |
| Drug | magnesium | 5.02e-05 | 1325 | 46 | 11 | CID000000888 | |
| Drug | gamma-Glu-Gly | 5.71e-05 | 37 | 46 | 3 | CID000100099 | |
| Drug | agrocinopine | 5.96e-05 | 6 | 46 | 2 | CID000127539 | |
| Drug | Pemetrexed | 8.38e-05 | 42 | 46 | 3 | ctd:D000068437 | |
| Drug | SCH 23390 | 8.85e-05 | 116 | 46 | 4 | CID000005018 | |
| Drug | hexadecanal | 9.07e-05 | 226 | 46 | 5 | CID000000984 | |
| Drug | 8-OH-DPAT | 9.15e-05 | 117 | 46 | 4 | CID000001220 | |
| Drug | Chlorpyrifos | 1.09e-04 | 960 | 46 | 9 | ctd:D004390 | |
| Drug | piperazine-2,3-dicarboxylic acid | 1.11e-04 | 8 | 46 | 2 | CID000280973 | |
| Drug | Iem 1460 | 1.11e-04 | 8 | 46 | 2 | CID003248290 | |
| Drug | Dieldrin | SLC17A2 SLC17A5 GRIA2 KLHL24 GALE GRIN2C YIF1B ENO1 ALK RBM34 | 1.28e-04 | 1217 | 46 | 10 | ctd:D004026 |
| Drug | m vs | 1.30e-04 | 244 | 46 | 5 | CID000000449 | |
| Drug | guanidinium | 1.32e-04 | 245 | 46 | 5 | CID000003520 | |
| Drug | haloperidol | 1.35e-04 | 394 | 46 | 6 | CID000003559 | |
| Drug | L-CCG-I | 1.42e-04 | 50 | 46 | 3 | CID000001271 | |
| Drug | AC1L1FA8 | 1.42e-04 | 50 | 46 | 3 | CID000003150 | |
| Drug | Sch 44342 | 1.42e-04 | 9 | 46 | 2 | CID009845545 | |
| Drug | SDMP | 1.42e-04 | 9 | 46 | 2 | CID000094924 | |
| Drug | NS-5 | 1.42e-04 | 9 | 46 | 2 | CID000194622 | |
| Drug | tipifarnib | 1.59e-04 | 52 | 46 | 3 | ctd:C402769 | |
| Drug | AC1L1EKQ | 1.59e-04 | 52 | 46 | 3 | CID000002834 | |
| Drug | Drugs, Chinese Herbal | 1.62e-04 | 586 | 46 | 7 | ctd:D004365 | |
| Drug | crizotinib | 1.68e-04 | 53 | 46 | 3 | ctd:C551994 | |
| Drug | GDC-0973 | 1.78e-04 | 10 | 46 | 2 | ctd:C574276 | |
| Drug | Guanosine Diphosphate | 1.78e-04 | 10 | 46 | 2 | ctd:D006153 | |
| Drug | LY 171555 | 1.93e-04 | 142 | 46 | 4 | CID000001257 | |
| Drug | Parathion | 2.15e-04 | 822 | 46 | 8 | ctd:D010278 | |
| Drug | YM872 | 2.17e-04 | 11 | 46 | 2 | CID000148200 | |
| Drug | Sulfur Dioxide | 2.20e-04 | 58 | 46 | 3 | ctd:D013458 | |
| Drug | 3,7-diaminoheptan-2-one | 2.56e-04 | 61 | 46 | 3 | CID004477684 | |
| Drug | nitric oxide | 2.56e-04 | 1075 | 46 | 9 | CID000145068 | |
| Drug | Insulin recombinant | 2.60e-04 | 12 | 46 | 2 | DB00030 | |
| Drug | isosteviol | 2.60e-04 | 12 | 46 | 2 | ctd:C515747 | |
| Drug | AP-7 | 2.82e-04 | 63 | 46 | 3 | CID000003122 | |
| Drug | Ethylnitrosourea | 2.94e-04 | 291 | 46 | 5 | ctd:D005038 | |
| Drug | 15d-PGJ2; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.97e-04 | 159 | 46 | 4 | 1011_UP | |
| Drug | Insulin, porcine | 3.07e-04 | 13 | 46 | 2 | DB00071 | |
| Drug | pinene | 3.07e-04 | 13 | 46 | 2 | CID000014896 | |
| Drug | 2-phenylpyridine | 3.07e-04 | 13 | 46 | 2 | CID000013887 | |
| Drug | Guanosine-5'-Diphosphate | 3.07e-04 | 13 | 46 | 2 | DB04315 | |
| Drug | f-Pt | 3.09e-04 | 65 | 46 | 3 | CID003000505 | |
| Drug | Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 3.35e-04 | 164 | 46 | 4 | 4985_UP | |
| Drug | NSC755875 | 3.42e-04 | 165 | 46 | 4 | CID000002215 | |
| Drug | L-Glutamic Acid | 3.53e-04 | 68 | 46 | 3 | DB00142 | |
| Drug | compound 4d | 3.58e-04 | 14 | 46 | 2 | CID000448577 | |
| Drug | TC-3 | 3.68e-04 | 69 | 46 | 3 | CID000398798 | |
| Drug | monensin; Up 200; 10.9uM; MCF7; HT_HG-U133A_EA | 3.83e-04 | 170 | 46 | 4 | 1105_UP | |
| Drug | (2S)-4-[[(2S)-1,4-bis(oxidanyl)-1-oxidanylidene-butan-2-yl]amino]-2-[[(3S)-3,4-bis(oxidanyl)-4-oxidanylidene-butyl]amino]butanoic acid | 3.84e-04 | 70 | 46 | 3 | CID009996931 | |
| Drug | Vanadium | 4.10e-04 | 173 | 46 | 4 | ctd:D014639 | |
| Drug | thiokynurenic acid | 4.12e-04 | 15 | 46 | 2 | CID003035667 | |
| Drug | AF I | 4.12e-04 | 15 | 46 | 2 | CID005287621 | |
| Drug | riluzole | 4.19e-04 | 174 | 46 | 4 | CID000005070 | |
| Drug | PNU-107859 | 4.19e-04 | 174 | 46 | 4 | CID004369084 | |
| Drug | a-factor | 4.35e-04 | 73 | 46 | 3 | CID000119102 | |
| Drug | alpha-aminoadipate | 4.35e-04 | 73 | 46 | 3 | CID000000469 | |
| Drug | Glucose | 4.46e-04 | 1420 | 46 | 10 | ctd:D005947 | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 4.47e-04 | 177 | 46 | 4 | 1072_UP | |
| Drug | Disulfiram [97-77-8]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 4.66e-04 | 179 | 46 | 4 | 6210_UP | |
| Drug | GTP - Na | 4.69e-04 | 923 | 46 | 8 | CID000000762 | |
| Drug | LY233536 | 4.71e-04 | 16 | 46 | 2 | CID000126239 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 4.96e-04 | 182 | 46 | 4 | 1661_UP | |
| Drug | Dioxins | 5.08e-04 | 934 | 46 | 8 | ctd:D004147 | |
| Drug | AC1MMF4B | 5.08e-04 | 77 | 46 | 3 | CID003260010 | |
| Drug | Thiostrepton [1393-48-2]; Up 200; 2.4uM; HL60; HT_HG-U133A | 5.17e-04 | 184 | 46 | 4 | 2462_UP | |
| Drug | 7-Cl-Thio-Kyna | 5.33e-04 | 17 | 46 | 2 | CID003035668 | |
| Drug | pinocembrin | 5.33e-04 | 17 | 46 | 2 | CID000068071 | |
| Drug | undecane | 5.33e-04 | 17 | 46 | 2 | CID000014257 | |
| Drug | bicyclol | 5.33e-04 | 17 | 46 | 2 | ctd:C477843 | |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 5.49e-04 | 187 | 46 | 4 | 3278_DN | |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Up 200; 9uM; PC3; HT_HG-U133A | 5.60e-04 | 188 | 46 | 4 | 3701_UP | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; MCF7; HT_HG-U133A | 5.72e-04 | 189 | 46 | 4 | 4688_UP | |
| Drug | 0297417-0002B [362658-29-5]; Up 200; 10uM; PC3; HT_HG-U133A | 5.72e-04 | 189 | 46 | 4 | 6895_UP | |
| Drug | Disulfiram [97-77-8]; Up 200; 13.4uM; PC3; HT_HG-U133A | 5.95e-04 | 191 | 46 | 4 | 5729_UP | |
| Drug | p 5a | 5.99e-04 | 18 | 46 | 2 | CID000447378 | |
| Disease | Nevus sebaceous | 3.79e-09 | 3 | 47 | 3 | C3854181 | |
| Disease | Inflammatory linear verrucous epidermal nevus | 3.79e-09 | 3 | 47 | 3 | C0473574 | |
| Disease | SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME | 3.79e-09 | 3 | 47 | 3 | 163200 | |
| Disease | Verrucous epidermal nevus | 3.79e-09 | 3 | 47 | 3 | C0362030 | |
| Disease | linear nevus sebaceous syndrome (is_implicated_in) | 3.79e-09 | 3 | 47 | 3 | DOID:0111530 (is_implicated_in) | |
| Disease | Noonan syndrome 3 (implicated_via_orthology) | 3.79e-09 | 3 | 47 | 3 | DOID:0060581 (implicated_via_orthology) | |
| Disease | Nevus Sebaceus of Jadassohn | 3.79e-09 | 3 | 47 | 3 | C4552097 | |
| Disease | Organoid Nevus Phakomatosis | 3.79e-09 | 3 | 47 | 3 | C0265329 | |
| Disease | Linear nevus sebaceous syndrome | 3.79e-09 | 3 | 47 | 3 | cv:C4552097 | |
| Disease | Linear Verrucous Epidermal Nevus | 3.79e-09 | 3 | 47 | 3 | C3179502 | |
| Disease | cervical cancer (implicated_via_orthology) | 3.79e-09 | 3 | 47 | 3 | DOID:4362 (implicated_via_orthology) | |
| Disease | RASopathy | 7.61e-09 | 15 | 47 | 4 | cv:C5555857 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 2.15e-08 | 19 | 47 | 4 | C3501846 | |
| Disease | Costello syndrome (disorder) | 2.15e-08 | 19 | 47 | 4 | C0587248 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 2.15e-08 | 19 | 47 | 4 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 2.15e-08 | 19 | 47 | 4 | C1275081 | |
| Disease | NEVUS, EPIDERMAL (disorder) | 3.78e-08 | 5 | 47 | 3 | C0334082 | |
| Disease | Follicular thyroid carcinoma | 3.78e-08 | 5 | 47 | 3 | C0206682 | |
| Disease | LEOPARD Syndrome | 4.05e-08 | 22 | 47 | 4 | C0175704 | |
| Disease | Noonan Syndrome | 5.86e-08 | 24 | 47 | 4 | C0028326 | |
| Disease | Hemimegalencephaly | 7.55e-08 | 6 | 47 | 3 | C0431391 | |
| Disease | RASopathy (implicated_via_orthology) | 3.16e-07 | 9 | 47 | 3 | DOID:0080690 (implicated_via_orthology) | |
| Disease | Noonan syndrome | 3.16e-07 | 9 | 47 | 3 | cv:C0028326 | |
| Disease | Turner Syndrome, Male | 6.19e-07 | 11 | 47 | 3 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 6.19e-07 | 11 | 47 | 3 | C1527404 | |
| Disease | Noonan Syndrome 1 | 6.19e-07 | 11 | 47 | 3 | C4551602 | |
| Disease | kidney cancer (implicated_via_orthology) | 6.19e-07 | 11 | 47 | 3 | DOID:263 (implicated_via_orthology) | |
| Disease | Neuroblastoma | 9.58e-07 | 47 | 47 | 4 | C0027819 | |
| Disease | Mouth Neoplasms | 1.69e-06 | 54 | 47 | 4 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 1.69e-06 | 54 | 47 | 4 | C0153381 | |
| Disease | Melanocytic nevus | 2.48e-06 | 2 | 47 | 2 | cv:C0027962 | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 2.48e-06 | 2 | 47 | 2 | C2674723 | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 2.48e-06 | 2 | 47 | 2 | 614470 | |
| Disease | Autoimmune lymphoproliferative syndrome type 4 | 2.48e-06 | 2 | 47 | 2 | cv:C2674723 | |
| Disease | autoimmune lymphoproliferative syndrome type 4 (is_implicated_in) | 2.48e-06 | 2 | 47 | 2 | DOID:0110117 (is_implicated_in) | |
| Disease | large congenital melanocytic nevus (is_implicated_in) | 2.48e-06 | 2 | 47 | 2 | DOID:0111359 (is_implicated_in) | |
| Disease | MELANOCYTIC NEVUS SYNDROME, CONGENITAL | 2.48e-06 | 2 | 47 | 2 | 137550 | |
| Disease | Large congenital melanocytic nevus | 2.48e-06 | 2 | 47 | 2 | cv:C1842036 | |
| Disease | melanoma | 2.67e-06 | 248 | 47 | 6 | C0025202 | |
| Disease | leukemia (implicated_via_orthology) | 3.60e-06 | 19 | 47 | 3 | DOID:1240 (implicated_via_orthology) | |
| Disease | Non-Small Cell Lung Carcinoma | 4.97e-06 | 156 | 47 | 5 | C0007131 | |
| Disease | GIANT PIGMENTED HAIRY NEVUS | 7.44e-06 | 3 | 47 | 2 | C1842036 | |
| Disease | Papillary thyroid carcinoma | 1.09e-05 | 86 | 47 | 4 | C0238463 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 1.34e-05 | 29 | 47 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | Nevus, Keratinocytic, Nonepidermolytic | 1.49e-05 | 4 | 47 | 2 | C4011754 | |
| Disease | BLADDER CANCER | 1.49e-05 | 4 | 47 | 2 | 109800 | |
| Disease | Epidermal nevus | 1.49e-05 | 4 | 47 | 2 | cv:C0334082 | |
| Disease | Malignant tumor of urinary bladder | 1.49e-05 | 4 | 47 | 2 | cv:C0005684 | |
| Disease | NEVUS, EPIDERMAL | 1.49e-05 | 4 | 47 | 2 | 162900 | |
| Disease | Thyroid cancer, nonmedullary, 2 | 1.49e-05 | 4 | 47 | 2 | cv:C4225426 | |
| Disease | Malignant neoplasm of penis | 1.49e-05 | 4 | 47 | 2 | C0153601 | |
| Disease | Penile Neoplasms | 1.49e-05 | 4 | 47 | 2 | C0030849 | |
| Disease | Malignant tumor of cervix | 1.49e-05 | 4 | 47 | 2 | C0007847 | |
| Disease | epidermal nevus (is_implicated_in) | 1.49e-05 | 4 | 47 | 2 | DOID:0111162 (is_implicated_in) | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 1.49e-05 | 4 | 47 | 2 | 188470 | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.49e-05 | 30 | 47 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 1.82e-05 | 32 | 47 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 1.91e-05 | 206 | 47 | 5 | C0152013 | |
| Disease | prostate cancer (implicated_via_orthology) | 2.00e-05 | 33 | 47 | 3 | DOID:10283 (implicated_via_orthology) | |
| Disease | DiGeorge syndrome (is_implicated_in) | 2.48e-05 | 5 | 47 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 2.48e-05 | 5 | 47 | 2 | C4225426 | |
| Disease | Malignant neoplasm of thyroid | 2.48e-05 | 5 | 47 | 2 | C0007115 | |
| Disease | Cetuximab response | 2.48e-05 | 5 | 47 | 2 | cv:CN077967 | |
| Disease | Cervix carcinoma | 2.48e-05 | 5 | 47 | 2 | C0302592 | |
| Disease | Panitumumab response | 2.48e-05 | 5 | 47 | 2 | cv:CN077999 | |
| Disease | Thyroid Neoplasm | 2.83e-05 | 37 | 47 | 3 | C0040136 | |
| Disease | heart disease (implicated_via_orthology) | 3.07e-05 | 38 | 47 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | Autoimmune lymphoproliferative syndrome | 3.71e-05 | 6 | 47 | 2 | cv:CN301239 | |
| Disease | Carcinoma in situ of uterine cervix | 3.71e-05 | 6 | 47 | 2 | C0851140 | |
| Disease | seminoma (is_implicated_in) | 3.71e-05 | 6 | 47 | 2 | DOID:4440 (is_implicated_in) | |
| Disease | Pleocytosis | 3.71e-05 | 6 | 47 | 2 | C0151857 | |
| Disease | Leukocytosis | 3.71e-05 | 6 | 47 | 2 | C0023518 | |
| Disease | Cutaneous Melanoma | 3.87e-05 | 41 | 47 | 3 | C0151779 | |
| Disease | high grade glioma (implicated_via_orthology) | 4.79e-05 | 44 | 47 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | Thyroid carcinoma | 4.79e-05 | 44 | 47 | 3 | C0549473 | |
| Disease | Thyroid cancer, follicular | 5.19e-05 | 7 | 47 | 2 | C2931367 | |
| Disease | Cardiomyopathies | 5.54e-05 | 130 | 47 | 4 | C0878544 | |
| Disease | Alzheimer's disease biomarker measurement, brain volume measurement | 6.91e-05 | 8 | 47 | 2 | EFO_0006514, EFO_0006930 | |
| Disease | Noonan syndrome (is_implicated_in) | 6.91e-05 | 8 | 47 | 2 | DOID:3490 (is_implicated_in) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 8.47e-05 | 145 | 47 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 1.11e-04 | 10 | 47 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | Carcinomatosis | 1.33e-04 | 163 | 47 | 4 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 1.33e-04 | 163 | 47 | 4 | C0205697 | |
| Disease | Undifferentiated carcinoma | 1.33e-04 | 163 | 47 | 4 | C0205698 | |
| Disease | Anaplastic carcinoma | 1.33e-04 | 163 | 47 | 4 | C0205696 | |
| Disease | entorhinal cortical volume, Alzheimer's disease biomarker measurement | 1.35e-04 | 11 | 47 | 2 | EFO_0005092, EFO_0006514 | |
| Disease | Carcinoma | 1.36e-04 | 164 | 47 | 4 | C0007097 | |
| Disease | carcinoma (implicated_via_orthology) | 1.47e-04 | 64 | 47 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | Neoplasms, Experimental | 1.62e-04 | 66 | 47 | 3 | C0027659 | |
| Disease | middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement | 1.92e-04 | 13 | 47 | 2 | EFO_0006514, EFO_0010316 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.99e-04 | 181 | 47 | 4 | DOID:684 (is_implicated_in) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.01e-04 | 71 | 47 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | whole-brain volume, Alzheimer's disease biomarker measurement | 2.23e-04 | 14 | 47 | 2 | EFO_0005089, EFO_0006514 | |
| Disease | Rhabdomyosarcoma | 2.57e-04 | 15 | 47 | 2 | C0035412 | |
| Disease | dysmenorrheic pain measurement | 2.94e-04 | 16 | 47 | 2 | EFO_0007889 | |
| Disease | Hemangiosarcoma | 3.74e-04 | 18 | 47 | 2 | C0018923 | |
| Disease | Juvenile Myelomonocytic Leukemia | 4.17e-04 | 19 | 47 | 2 | C0349639 | |
| Disease | Adenocarcinoma of large intestine | 4.88e-04 | 96 | 47 | 3 | C1319315 | |
| Disease | Splenomegaly | 5.62e-04 | 22 | 47 | 2 | C0038002 | |
| Disease | Carcinoma of lung | 6.15e-04 | 23 | 47 | 2 | C0684249 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GIIYKQGGVASGMKH | 111 | O75366 | |
| QGMVAKGTTGYKAGF | 361 | Q9NY47 | |
| VKGKGEMTTYFLNGG | 1151 | O43306 | |
| TLGKVGEGSYGTVMK | 6 | Q8IVW4 | |
| GAKGLMGPFSKEIYG | 891 | Q9UDR5 | |
| YPVMIKASEGGGGKG | 306 | Q13085 | |
| GKPKGVVHTVGGYML | 321 | Q9NR19 | |
| DGGIYIGSIMKGGAV | 291 | O14641 | |
| MTEYKLVVVGAGGVG | 1 | P01112 | |
| MTEYKLVVVGAGGVG | 1 | P01116 | |
| MTEYKLVVVGAGGVG | 1 | P01111 | |
| IFKYIIIGDMGVGKS | 11 | P61106 | |
| GQTIGGKMLDKYIYG | 71 | P51157 | |
| DKMTGIGKGFGYVLF | 321 | P42696 | |
| MREYKVVVLGSGGVG | 1 | P10114 | |
| MREYKVVVLGSGGVG | 1 | P61225 | |
| MREYKVVVLGSGGVG | 1 | Q9Y3L5 | |
| MVVLGGKVYVIGGFD | 416 | Q8WZ60 | |
| KAKANGITMYAVGVG | 781 | O00339 | |
| TKGVQAVMGYKPGSG | 606 | Q9H089 | |
| GLKGYVAAGTCLMQG | 1116 | Q10570 | |
| GGKASNMAVVYGKEA | 456 | Q3V5L5 | |
| TMKVGGNLDSKGYGI | 741 | P42262 | |
| GELMGYIMGKAEGSV | 51 | P61599 | |
| LKSIIGMGTGAGAYI | 131 | Q92597 | |
| IEGKYLGKLGVSGML | 1261 | Q8IWU2 | |
| MAEKVLVTGGAGYIG | 1 | Q14376 | |
| IGKAGYTDKVVIGMD | 231 | P06733 | |
| KMAVLLGKVYVVGGY | 401 | Q6TFL4 | |
| EMVKGGYTLDSNKGG | 781 | Q08554 | |
| GGIYIGSIMKGGAVA | 276 | O14640 | |
| KMGEGGFGVVYKGYV | 191 | Q9NWZ3 | |
| GGIYIGSIMKGGAVA | 276 | P54792 | |
| GGYVASKIGGKMLLG | 126 | Q9NRA2 | |
| GKSYSMIGFGCKQGI | 116 | B7ZC32 | |
| KYGLGFQIIGGEKMG | 1101 | Q12923 | |
| MIDVIGVTKGKGYKG | 216 | P39023 | |
| YKVVMLGAGGVGKSA | 21 | Q99578 | |
| GGGATYVFKMKDGVP | 821 | Q9UM73 | |
| LGYKYVGMIGGVLMG | 226 | Q5BJH7 | |
| EYKLVMLGAGGVGKS | 21 | Q92963 | |
| YLAGIFGAKKMLGAG | 111 | O00624 | |
| GYGDMKPITVGGKIV | 526 | P22459 | |
| ESGAGKTVAAKYIMG | 111 | O00160 | |
| KYIMGYISKVSGGGE | 121 | O00160 | |
| GVGVAYNSKVGGIRM | 226 | P29120 | |
| GKVFATTGYGIAMQK | 751 | Q14957 | |
| YTGKGVTIGIMDDGI | 156 | P16519 |